These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12120626)

  • 21. [Sibutramine and its adequate usage].
    Nagayama D; Shirai K
    Nihon Rinsho; 2011 Jan; 69 Suppl 1():678-82. PubMed ID: 21766680
    [No Abstract]   [Full Text] [Related]  

  • 22. Genotype-dependent response to energy-restricted diets in obese subjects: towards personalized nutrition.
    Martinez JA; Parra MD; Santos JL; Moreno-Aliaga MJ; Marti A; Martinez-Gonzalez MA
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():119-22. PubMed ID: 18296317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obesity. Pathogenesis, consequences, and approaches to treatment.
    Weiss SR
    Psychiatr Clin North Am; 1984 Jun; 7(2):307-19. PubMed ID: 6473186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of 1-yr sibutramine treatment on glucose tolerance, insulin sensitivity and serum lipid profiles in obese subjects.
    Sabuncu T; Ucar E; Birden F; Yasar O
    Diabetes Nutr Metab; 2004 Apr; 17(2):103-7. PubMed ID: 15244102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Energy-restricted diets based on a distinct food selection affecting the glycemic index induce different weight loss and oxidative response.
    Abete I; Parra D; Martinez JA
    Clin Nutr; 2008 Aug; 27(4):545-51. PubMed ID: 18308431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapy and weight-loss drugs. Clinical aspects].
    Appetecchia M; Orofino G
    Minerva Med; 1990 Mar; 81(3):191-5. PubMed ID: 2181348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful treatment of a morbidly obese and growth-retarded adolescent with Williams-Beuren Syndrome by combining the medication of growth hormone and sibutramine.
    Bahadori B; Uitz E; Tonninger-Bahadori K; Moghadasian MH
    Singapore Med J; 2008 Jan; 49(1):e15-6. PubMed ID: 18204753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A drug help in reducing? Risk profile decides whether and how].
    Hauner H
    MMW Fortschr Med; 2003 May; 145(21):60. PubMed ID: 12845877
    [No Abstract]   [Full Text] [Related]  

  • 29. Catatonia and psychosis associated with sibutramine: a case report and pathophysiologic correlation.
    Lee J; Teoh T; Lee TS
    J Psychosom Res; 2008 Jan; 64(1):107-9. PubMed ID: 18158006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of sibutramine-induced weight loss on cardiovascular system in obese subjects.
    de Simone G; Romano C; De Caprio C; Contaldo F; Salanitri T; di Luzio Paparatti U; Pasanisi F
    Nutr Metab Cardiovasc Dis; 2005 Feb; 15(1):24-30. PubMed ID: 15871847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Weight loss lowers blood pressure, lipids and blood glucose. Sibutramine also helps diabetics with weight loss].
    MMW Fortschr Med; 2002 Sep; 144(37):56. PubMed ID: 12380343
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prevention of sequelae following obesity by prolonged weight reducing diets].
    Aszódi Z
    Orv Hetil; 1965 Sep; 106(36):1686-91. PubMed ID: 5825294
    [No Abstract]   [Full Text] [Related]  

  • 33. [Control of obesity].
    Beiul EA; Popova IuP
    Klin Med (Mosk); 1990 Aug; 68(8):106-10. PubMed ID: 2084359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapy of obesity].
    Wechsler JG
    Internist (Berl); 1995 Nov; 36(11):1063-9. PubMed ID: 8543442
    [No Abstract]   [Full Text] [Related]  

  • 35. [Differentiated indications in the treatment of obesity: current data].
    Laurent-Jaccard A
    Schweiz Rundsch Med Prax; 1986 Jun; 75(23):706-9. PubMed ID: 3726368
    [No Abstract]   [Full Text] [Related]  

  • 36. [Conservative therapy of obesity].
    Wechsler JG
    Zentralbl Chir; 1996; 121(5):358-62. PubMed ID: 8677695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diets, drugs, exercise, and behavioral modification: Where these work and where they do not.
    Kushner R
    Surg Obes Relat Dis; 2005; 1(2):120-2. PubMed ID: 16925226
    [No Abstract]   [Full Text] [Related]  

  • 38. Sibutramine: balancing weight loss benefit and possible cardiovascular risk.
    de Simone G; D'Addeo G
    Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):337-41. PubMed ID: 18502626
    [No Abstract]   [Full Text] [Related]  

  • 39. The new role of pharmacotherapy for weight reduction in obesity.
    Fernstrom MH; Fernstrom JD
    Int J Clin Pract; 2002 Nov; 56(9):683-6. PubMed ID: 12469983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of sibutramine on weight reduction and insulin resistance in women with polycystic ovary syndrome.
    Georgopoulos NA; Katsikis I; Florakis D; Panidis D; Kandarakis ED
    Fertil Steril; 2009 Jun; 91(6):e1. PubMed ID: 19362719
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.